Navigation Links
Data Published in Circulation Journal Show OrbusNeich's Genous™ Stent Is Safe and Effective in Elderly Patients
Date:10/25/2011

HONG KONG, Oct. 25, 2011 /PRNewswire/ -- OrbusNeich today announced the publication of 12-month follow-up data from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry in Circulation Journal that show the Genous Stent is safe and effective in elderly patients.

In the study, no significant difference in stent thrombosis (ST) was observed at 12 months between elderly patients (aged 65 or older) and younger patients. The target lesion revascularization (TLR) rate was not significantly higher with increasing age. Target vessel failure (TVF), the main outcome of the study, was observed more often in elderly patients; TVF occurred in 11.7 percent of patients over the age of 75, in 8.8 percent of patients between the ages of 65 and 74, and in 7 percent of patients younger than 65. The increased rate of TVF in elderly patients was driven mainly by increased mortality.

"Early discontinuation of dual antiplatelet therapy (DAPT) has been identified as a major predictor for the occurrence of ST, and for this reason the elderly are at a particularly high-risk for ST due to their expected non-compliance with DAPT," said Dr. Andres Iniguez of the University of Vigo, Spain. "The elderly comprise an important subgroup of patients for whom long-term DAPT may not be advisable, and these data show that in patients over 65 the Genous Stent was safe and did not lead to an increased risk of ST despite their lower compliance."

The registry's main outcome was TVF at 12-month follow-up, defined as the composite of cardiac death or myocardial infarction (MI) unless unequivocally attributable to a non-target vessel and target vessel revascularization (TVR). Secondary outcomes were the composite of cardiac death, MI and clinically-indicated TLR, the individual outcomes all-cause death, cardi
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Semler Scientific, Inc. (Nasdaq: ... company that develops patented products that assist healthcare ... today reported financial results for the third quarter ... "In the third quarter of 2014, ... M.D., chief executive officer of Semler.  "We moved ...
(Date:10/31/2014)... 31, 2014  Zebra Imaging, Inc., the world,s ... today a strategic partnership with the Zygote Media ... anatomy and biomedical models for animation and visual ... markets.  Zygote maintains the world,s most comprehensive library ... has pioneered development of high-end solid 3D anatomy ...
(Date:10/31/2014)... SAN FRANCISCO , Oct. 31, 2014 /PRNewswire/ ... innovative therapeutics, today announced a $26.5 million Series ... global investment firm founded by a team of ... sciences.  Other investors participating in the round include ... Venture Fund.  Representatives from Clarus Ventures and Frazier ...
Breaking Medicine Technology:Semler Reports Third Quarter 2014 Financial Results 2Semler Reports Third Quarter 2014 Financial Results 3Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2
... Oct. 6, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ... lorcaserin presentations at Obesity 2010, the 28th Annual Scientific ... Lorcaserin, which Arena discovered and developed, is intended for ... loss, in patients who are obese (Body Mass Index, ...
... N.J., and SAN ANTONIO, Oct. 6 ... company, and Mission Pharmacal Company, a privately-held ... market announced today their exclusive co-promotion agreement ... to obstetrician,s, gynecologists and other women,s health ...
Cached Medicine Technology:Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010 2Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010 3Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010 4Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Women's Health Market 2Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Women's Health Market 3Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Women's Health Market 4
(Date:10/31/2014)... Nearly one out of four older Americans say that ... or unwanted medical treatment, according to the latest issue ... & Aging Report ( PP&AR ), which goes ... accountable when they fail to honor patients, end-of-life health ... Advanced Illness Care: Issues and Options ," features 12 ...
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 ... reveals that this workout program was developed by Dan ... also become well-known as a fitness professional and life ... stubborn fat and having toned muscles is not impossible ... in based on suspension training. Suspension training promises efficiency ...
(Date:10/31/2014)... drug combination that can trigger the self-destruct process in ... treatments, according to research that will be presented at ... Liverpool next week*. , When healthy cells are no ... in self destruction. But cancer cells swerve away from ... cells grow out of control – causing tumours to ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 In an effort ... patients, Dr. Majid Jamali announced he will soon offer orthodontics ... by the end of November. , To build upon ... Surgery of New York has become known for, Dr. Jamali ... degrees from such top learning institutions as UCLA, Stanford and ...
(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its new report, ... indoor air quality (IAQ) market is expected to grow to ... (CAGR) of 7% over the next five years. The equipment ... 7.4%. , Since 2012, continuing media attention focused on ... diseases such as bird flu and the increase in chronic ...
Breaking Medicine News(10 mins):Health News:Advance directives can benefit patients, families, and health care system 2Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Scientists trigger self-destruct switch in lung cancer cells 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 2Health News:Oral & Maxillofacial Surgery of New York Adds Orthodontic Patient Services 3Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3
... Encouraging Families to Be Incredibly Active and Healthy, American Egg ... 13 Today, the nation,s egg farmers will delight thousands ... eggs for the 2009 White House Easter Egg Roll. ... together families to hunt for and race Easter Eggs on ...
... used tiny molecules called microRNAs to help turn adult mouse cells back to ... stem cells , they have the capacity to become any cell type in ... ... researchers has for the first time used tiny molecules called microRNAs to help ...
... lung cancer are less likely to receive recommended chemotherapy and ... no signs of lessening. That is the conclusion of a ... CANCER , a peer-reviewed journal of the American Cancer ... provide appropriate treatments for black patients and to educate them ...
... notion that females only receive finite number of eggs ... Researchers in China have demonstrated that female ovaries may ... subsequently producing offspring. , That runs counter to the ... with a finite number of the eggs or oocytes ...
... ValueRays® ergonomic computer accessories provide infrared heat therapy using infrared ... your hand pain diagnosis results in cold computer hands and ... your computer provides warmth and relief. , ... ...
... Discovery advances search for better treatments, experts say, , , ... they,ve spotted a gene variant that may raise the ... may lead to new drug treatments. , The study ... had multiple members with schizophrenia. A functional DNA change ...
Cached Medicine News:Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 2Health News:America's Egg Farmers to Participate in Annual White House Easter Egg Roll Today 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 2Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 3Health News:UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells 4Health News:Racial disparities persist in the treatment of lung cancer 2Health News:Stem Cells Spur New Eggs in Ovaries of Adult Mice 2Health News:Stem Cells Spur New Eggs in Ovaries of Adult Mice 3Health News:Arthritis Hand Pain Relief: Infrared Heat Therapy Ergonomic Computer Workstation 2Health News:Gene Variant Tied to Schizophrenia 2
The Skirts and Vests are made with .50mm Pb in the front and .25mm Pb in the back. When worn, the overlap areas in the front of both the skirt and vest provide 1.0mm Pb protection. The velcro fastene...
Designed to fit the body and priced to fit the budget! The Economy Tie apron has a belt that wraps around the body and ties in the front. Don't let the price fool you.... this apron provides the same...
Setting a new standard in protective apparel. The unique, patented Cool-Tech™ mesh-back design fits the natural contour of the body while reducing the amount of weight carried on the shoulders ...
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Medicine Products: